News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,517 Results
Type
Article (87193)
Company Profile (705)
Press Release (769595)
Multimedia
Podcasts (162)
Webinars (24)
Section
Business (232956)
Career Advice (4136)
Deals (39778)
Drug Delivery (133)
Drug Development (91190)
Employer Resources (200)
FDA (18243)
Job Trends (17384)
News (397159)
Policy (39889)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (115)
Alliances (56979)
ALS (134)
Alzheimer's disease (1637)
Antibody-drug conjugate (ADC) (203)
Approvals (18228)
Artificial intelligence (446)
Autoimmune disease (43)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (483)
Bladder cancer (116)
Brain cancer (46)
Breast cancer (431)
Cancer (3468)
Cardiovascular disease (300)
Career advice (3550)
Career pathing (36)
CAR-T (225)
CDC (45)
Cell therapy (618)
Cervical cancer (29)
Clinical research (74839)
Collaboration (1254)
Company closure (4)
Compensation (844)
Complete response letters (47)
COVID-19 (2939)
CRISPR (74)
C-suite (478)
Cystic fibrosis (128)
Data (3644)
Decentralized trials (2)
Denatured (58)
Depression (92)
Diabetes (409)
Diagnostics (7034)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (211)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (179)
Earnings (98616)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132316)
Executive appointments (947)
FDA (20428)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1113)
Gene editing (160)
Generative AI (44)
Gene therapy (489)
GLP-1 (982)
Government (5339)
Grass and pollen (7)
Guidances (330)
Healthcare (20934)
HIV (48)
Huntington's disease (32)
IgA nephropathy (52)
Immunology and inflammation (207)
Immuno-oncology (17)
Indications (45)
Infectious disease (3153)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (155)
Interviews (814)
IPO (17919)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (67)
Layoffs (619)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (494)
Lymphoma (250)
Machine learning (18)
Management (65)
Manufacturing (545)
MASH (115)
Medical device (14812)
Medtech (14829)
Mergers & acquisitions (22662)
Metabolic disorders (1049)
Multiple sclerosis (114)
NASH (23)
Neurodegenerative disease (177)
Neuropsychiatric disorders (49)
Neuroscience (2506)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (528)
Opinion (302)
Ovarian cancer (112)
Pain (149)
Pancreatic cancer (142)
Parkinson's disease (212)
Partnered (27)
Patents (377)
Patient recruitment (250)
Peanut (56)
People (66010)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23072)
Phase II (32494)
Phase III (24466)
Pipeline (2403)
Policy (276)
Postmarket research (3554)
Preclinical (10419)
Press Release (72)
Prostate cancer (169)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (588)
Real estate (7409)
Recruiting (76)
Regulatory (27623)
Reports (64)
Research institute (2672)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (15)
RSV (62)
Schizophrenia (115)
Series A (183)
Series B (137)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (39)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (102)
Vaccines (998)
Venture capital (63)
Weight loss (363)
Women's health (56)
Worklife (21)
Date
Today (122)
Last 7 days (754)
Last 30 days (2555)
Last 365 days (34177)
2025 (23056)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (77)
Alaska (7)
Arizona (292)
Arkansas (14)
Asia (50763)
Australia (8914)
California (8784)
Canada (2663)
China (820)
Colorado (370)
Connecticut (389)
Delaware (237)
Europe (116563)
Florida (1300)
Georgia (302)
Hawaii (3)
Idaho (67)
Illinois (783)
India (45)
Indiana (424)
Iowa (19)
Japan (264)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1202)
Massachusetts (6638)
Michigan (294)
Minnesota (537)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (99)
New Hampshire (75)
New Jersey (2421)
New Mexico (31)
New York (2398)
North Carolina (1343)
North Dakota (10)
Northern California (3904)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1845)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3320)
Tennessee (142)
Texas (1366)
United States (32670)
Utah (263)
Virginia (237)
Washington D.C. (82)
Washington State (755)
West Virginia (4)
Wisconsin (90)
There are 857,517 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
September 9, 2025
·
7 min read
Press Releases
BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA
September 9, 2025
·
8 min read
Press Releases
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting
September 9, 2025
·
6 min read
Press Releases
AMO Pharma Enters into License Agreement with Population Health Research Institute (PHRI) and Venca Research Inc. to Advance Largest-Ever Study in Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
September 9, 2025
·
4 min read
Press Releases
IDEAYA Biosciences Announces Positive Data From Phase 1/2 Combination Trial of IDE397, a potential first-in-class MAT2A inhibitor, and Trodelvy® in MTAP-Deletion Urothelial Cancer
September 9, 2025
·
6 min read
Press Releases
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
September 9, 2025
·
5 min read
Press Releases
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
September 9, 2025
·
7 min read
Press Releases
Pelthos Therapeutics to Participate in Upcoming September 2025 Investor Conferences
September 9, 2025
·
1 min read
Press Releases
Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
September 9, 2025
·
4 min read
Press Releases
I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments
September 9, 2025
·
8 min read
1 of 85,752
Next
